KD Pharma Group | Creating Health Solutions
The KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation and encapsulation services, with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents.
|
|
|
201-500 employees
View all KD Pharma employees
|
|
Pharmaceuticals
|
|
Via Campagna 30, Bioggio, Tesino 6934, CH
|
|
1988
|
|
Algae, Apis, Catalysis, Cbd, Softgels, Plant Extracts, Cdmo, Fish Oil, Cannabidiol, Epa And Dha Concentrates, Ethyl Esters, Free Fatty Acids, Monoglycerides, Omega-3 Apis, Omega-3 Concentrates, Sfc Technology, Triglycerides, Pharmaceutical Synthesis
|
Wang Kai is the CEO of KD Pharma Group.
The decision makers in KD Pharma are Birgitta Bjorkenas, Chiamiran Vuap Auer, Daniel Wiley, etc. Click to Find KD Pharma decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.